Florbetaben

CHEMBL1908906 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
358.4 g/mol
LogP
4.2
Phase
4

This radioactive imaging agent is used in PET scans to help doctors detect amyloid plaques in the brain, which are associated with Alzheimer's disease.

Peso Molecular

358,4000 g/mol

LogP

4,20

TPSA

39,70 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)cc2)cc1

InChI

InChI=1S/C21H26FNO3/c1-23-20-8-4-18(5-9-20)2-3-19-6-10-21(11-7-19)26-17-16-25-15-14-24-13-12-22/h2-11,23H,12-17H2,1H3/b3-2+

Molecular Formula

C21H26FNO3

HBD / HBA

1 / 5

Ligações Rotacionáveis

12

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This radioactive imaging agent is used in PET scans to help doctors detect amyloid plaques in the brain, which are associated with Alzheimer's disease.

Yes, Florbetaben is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908906. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11501341. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.